X
Staff Correspondent

Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020.

  • Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019
  • Net sales decreased 41% to $58.3 million
  • Capital expenditures during the quarter was $1.5 million

Looking forward to listening to management/analysts comments on Q4 results? Stay tuned here for AngioDynamics Q4 2020 earnings call transcript

Categories: AlphaGraphs Earnings Health Care
Tags: Medical Devices
Related Post
  1. BIDU Earnings: Baidu Q3 2024 adjusted profit drops on lower revenues

    Internet search service provider Baidu, Inc. (NASDAQ: BIDU) Thursday reported a decline in adjusted profit…

  2. INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

    Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of…

  3. Key highlights from Deere & Co.’s (DE) Q4 2024 earnings results

    Deere & Company (NYSE: DE) reported its fourth quarter 2024 earnings results today. Worldwide net…

PRODUCTS

ABOUT US

GROUPS